Unmasking Multiple Sclerosis

Unmasking Multiple Sclerosis

Multiple SCLEROSIS Awareness March is Multiple Sclerosis (MS) Awareness Month, so this WEEKLY takes a look at the science behind the disease and some of the treatments developed for it. MS typically occurs in susceptible individuals between the ages of 20 and 50, and...
Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer’s disease: A tough nut to crack September 21 is World Alzheimer’s Day, a day focused on raising awareness of Alzheimer’s disease (AD). This week and next, we’ll review what is known about AD, and summarize novel treatments in development. Alzheimer’s...
The ABCs Of Hepatitis

The ABCs Of Hepatitis

Hepatitis Viruses Explained Curing disease is serious business. Lou Reed, the infamous leader of the rock band Velvet Underground, died in 2013 of complications from hepatitis C and liver disease. Death is the most profound fear for people living with hepatitis C, but...
The Many Faces Of Botox

The Many Faces Of Botox

THE MANY FACES OF BOTOX Botox.  This powerful protein has become somewhat of a meme for people of a certain age wanting to look less than that age. Botox’s applications, however, go far beyond the cosmetic, as recent industry headlines about AbbVie’s (North Chicago,...
PARP1 Inhibitor Takes On Pancreatic Cancer

PARP1 Inhibitor Takes On Pancreatic Cancer

PARP1 INHIBITORs PARP1 inhibitors are back in the headlines this week, as Astra Zeneca’s (Cambridge, England) and Merck’s (Kenilworth, New Jersey) Lynparza posted positive Phase III results from a trial with pancreatic cancer patients—a notoriously difficult...